Palvella Therapeutics (PVLA) Non-Current Deffered Revenue (2016 - 2023)
Palvella Therapeutics' Non-Current Deffered Revenue was $759,000 in Q2 2023, down 96.6% from $22.06 million a year earlier and down 93.5% from the prior quarter.
Palvella Therapeutics (PVLA) Non-Current Deffered Revenue (2016 - 2023) Analysis & Trends
At the end of FY2022, Non-Current Deffered Revenue at Palvella Therapeutics came in at $18.73 million, down 51.2% from FY2021.
- Non-Current Deffered Revenue shows a five-year compound annual growth rate of -16.6% (FY2017 to FY2022).
- In earlier years, Non-Current Deffered Revenue was $38.4 million in FY2021 (+7.0%), $35.9 million in FY2020 (-24.0%), $47.26 million in FY2019 (-11.3%) and $53.3 million in FY2018 (+14.5%).
- The Q2 2023 figure marks the lowest quarterly Non-Current Deffered Revenue in data going back to Q1 2016.
- Compared with a year earlier, Non-Current Deffered Revenue has declined for six straight quarters, with an average decline of 37.2% over the last eight quarters.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q2 2021 (growth of 30.6%); the worst was Q2 2023 (a decline of 96.6%).
- Per Business Quant data, PVLA's Non-Current Deffered Revenue in the three quarters before Q2 2023 was $11.73 million (Q1 2023), $18.73 million (Q4 2022) and $18.48 million (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Palvella Therapeutics | 1.99 Bn | 1.73 Bn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 759,000.00 |
| Mar 31, 2023 | 11.73 Mn |
| Dec 31, 2022 | 18.73 Mn |
| Sep 30, 2022 | 18.48 Mn |
| Jun 30, 2022 | 22.06 Mn |
| Mar 31, 2022 | 30.82 Mn |
| Dec 31, 2021 | 38.40 Mn |
| Sep 30, 2021 | 46.19 Mn |
| Jun 30, 2021 | 49.42 Mn |
| Mar 31, 2021 | 32.32 Mn |
| Dec 31, 2020 | 35.90 Mn |
| Sep 30, 2020 | 36.92 Mn |
| Jun 30, 2020 | 37.85 Mn |
| Mar 31, 2020 | 38.56 Mn |
| Dec 31, 2019 | 47.26 Mn |
| Sep 30, 2019 | 44.18 Mn |
| Jun 30, 2019 | 58.11 Mn |
| Mar 31, 2019 | 59.73 Mn |
| Dec 31, 2018 | 53.30 Mn |
| Sep 30, 2018 | 60.77 Mn |
Palvella Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PVLA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();